Duchier J
Hôpital de Saint-Cloud et Thérapharm-Recherches, Paris.
Agressologie. 1990 Feb;31(2):87-91.
It is impossible to extrapolate for men the animal's data. Pre-therapeutical studies are a necessity to state precisely in man ADME for a new drug and to confirm pharmacological properties seen in animals. Very often, the only healthy volunteers are useful for Phase 1 studies: The selection of volunteers keeps physical and metabolic status, and psychological motivation. True but restricted information is necessary for "free and informed consent". Rights and duties must be clearly defined in written convention. Financial advantages are in agreement of trouble but not of hazard in the study. The safety is the main point in human studies. That means a safe methodology and a protocol approved by independent ethical committee. The monitoring of these studies must be precisely conducted with many clinical and laboratory examinations. Healthy volunteers studies are required by French Ministry of Health, rejected by medical law, condemned by civil law but covered by legal insurances. In French mind is illicit that is not specifically permitted by law. We need special legislation as we refuse medical and ethical responsibility.
将动物数据外推至人类是不可能的。治疗前研究对于准确阐明新药在人体的吸收、分布、代谢和排泄情况以及确认在动物身上观察到的药理特性是必要的。通常,只有健康志愿者对1期研究有用:志愿者的选择要考虑身体和代谢状况以及心理动机。对于“自由和知情同意”而言,真实但有限的信息是必要的。权利和义务必须在书面协议中明确界定。经济利益与研究中的不适相符,但与风险不符。安全性是人体研究的要点。这意味着要有安全的方法和独立伦理委员会批准的方案。这些研究的监测必须通过许多临床和实验室检查精确进行。法国卫生部要求进行健康志愿者研究,但被医事法驳回,被民法谴责,但受法律保险覆盖。在法国人的观念中,未经法律特别许可的就是非法的。由于我们拒绝承担医学和伦理责任,所以我们需要特别立法。